COVID Defense Act
This bill rescinds specified defense appropriations and authorizes funding for manufacturing and delivering COVID-19 vaccines internationally.
To rescind 1.3 percent of total defense spending and authorize the same 
  amount for international COVID vaccine production and distribution.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID Defense Act''.

SEC. 2. DEFENSE SPENDING RECISSION.

    Of the unobligated balances available from amounts made available 
pursuant to authorizations of appropriations contained in Public Law 
116-283, the William M. (Mac) Thornberry National Defense Authorization 
Act for Fiscal Year 2021, $9,626,500,000 is hereby rescinded. This 
recission shall apply on a pro rata basis among the accounts for which 
amounts were authorized other than those for the Defense Health 
Program, military personnel, and persons appointed into the civil 
service as defined in section 2101 of title 5, United States Code.

SEC. 3. AUTHORIZATION OF APPROPRIATIONS FOR INTERNATIONAL COVID VACCINE 
              PRODUCTION AND DISTRIBUTION.

    There is hereby authorized to be appropriated $9,626,500,000 to any 
Federal agency or agencies designated by the President of the United 
States to manufacture and deliver coronavirus vaccines internationally. 
Such funds may also be awarded to international organizations as 
appropriate.
                                 <all>
COVID Defense Act
To rescind 1.3 percent of total defense spending and authorize the same amount for international COVID vaccine production and distribution.
COVID Defense Act
Rep. Pocan, Mark